Characterization of absorbable collagen sponges as recombinant human bone morphogenetic protein-2 carriers

被引:42
|
作者
Friess, W
Uludag, H
Foskett, S
Biron, R
Sargeant, C
机构
[1] Univ Erlangen Nurnberg, Dept Pharmaceut Technol, D-91058 Erlangen, Germany
[2] Univ Alberta, Dept Biomed Engn, Edmonton, AB T6G 2G3, Canada
[3] Genet Inst Inc, Andover, MA 01810 USA
关键词
collagen; bone morphogenetic protein; sterilization; crosslinking;
D O I
10.1016/S0378-5173(99)00128-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
For clinical use recombinant human bone morphogenetic protein-2 (rhBMP-2) is soaked onto an absorbable collagen sponge (ACS) for bone regeneration. Therefore, loss of rhBMP-2 upon mechanical handling during implantation and a potential effect of the carrier on in vivo retention is of interest. The interactions between drug and carrier were looked at from the application mode and the amount of protein which can be mechanically expressed from the combination was investigated. The results indicated that rhBMP-2 binds to the collagen system. The most hydrophilic double extended homodimer showed the least binding affinity to ACS. By extending the waiting time between soaking and implantation, protein incorporation could be increased. In addition, the amount of rhBMP-2 which could be expressed was reduced by heavier ACS material and allowed for a shorter waiting period, especially at lower rhBMP-2 concentration. Crosslinking of ACS with formaldehyde led to reduced binding of rhBMP-2 to collagen either by direct hindrance of binding or reduction in swelling and number of binding sites available. Higher product pH or anion concentration enabled to increase rhBMP-2 incorporation but was limited by the potential precipitation of rhBMP-2. Despite a variety of chemical changes of ACS by ethylene oxide sterilization incorporation was not changed significantly. The in vivo release kinetics of I-125-rhBMP-2 from the collagen sponge were studied using a rat ectopic implant model. The ACS/rhBMP-2 systems tested demonstrated small but significant differences in the in vivo retention of rhBMP-2. Consequently, it is important to have as little variability in pH, anion concentration, crosslinking, and ACS mass as possible to achieve consistent or maximum binding and to avoid rhBMP-2 precipitation. Furthermore, these characteristics can be important for other in vivo applications. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:51 / 60
页数:10
相关论文
共 50 条
  • [1] Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration
    Hollinger, JO
    Schmitt, JM
    Buck, DC
    Shannon, R
    Joh, SP
    Zegzula, HD
    Wozney, J
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1998, 43 (04): : 356 - 364
  • [2] Comparison of two doses of recombinant human bone morphogenetic protein in absorbable collagen sponges for bone healing in dogs
    Schmiedt, Chad W.
    Lu, Yan
    Heaney, Kathleen
    Muir, Peter
    Amodie, Deborah M.
    Markel, Mark D.
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2007, 68 (08) : 834 - 840
  • [3] Recombinant human bone morphogenetic protein-2 in absorbable collagen sponge enhances bone healing of tibial osteotomies in dogs
    Faria, Maria L. E.
    Lu, Yan
    Heaney, Kathleen
    Uthamanthil, Rajesh K.
    Muir, Peter
    Markel, Mark D.
    VETERINARY SURGERY, 2007, 36 (02) : 122 - 131
  • [4] Bone regeneration with recombinant human bone morphogenetic protein-2 (rhBMP-2) using absorbable collagen sponges (ACS): Influence of processing on ACS characteristics and formulation
    Friess, W
    Uludag, H
    Foskett, S
    Biron, R
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 1999, 4 (03) : 387 - 396
  • [5] Recombinant human bone morphogenetic protein-2
    Shaffrey, Christopher I.
    Smith, Justin S.
    JOURNAL OF NEUROSURGERY-SPINE, 2013, 18 (02) : 109 - 110
  • [6] Bone formation in the goat maxillary sinus induced by absorbable collagen sponge implants impregnated with recombinant human bone morphogenetic protein-2
    Nevins, M
    KirkerHead, C
    Nevins, M
    Wozney, JA
    Palmer, R
    Graham, D
    INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY, 1996, 16 (01) : 9 - 19
  • [7] Axonal Loss in Murine Peripheral Nerves Following Exposure to Recombinant Human Bone Morphogenetic Protein-2 in an Absorbable Collagen Sponge
    Margolis, David S.
    Wu, Eileen W.
    Truchan, Lisa M.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2013, 95A (07): : 611 - 619
  • [8] Recombinant human bone morphogenetic protein-2 Response
    Burkus, J. Kenneth
    JOURNAL OF NEUROSURGERY-SPINE, 2013, 18 (02) : 110 - 111
  • [9] Local bone formation by injection of recombinant human bone morphogenetic protein-2 contained in polymer carriers
    Saito, N
    Okada, T
    Horiuchi, H
    Ota, H
    Takahashi, J
    Murakami, N
    Nawata, M
    Kojima, S
    Nozaki, K
    Takaoka, K
    BONE, 2003, 32 (04) : 381 - 386
  • [10] Promising Efficacy of Escherichia coli Recombinant Human Bone Morphogenetic Protein-2 in Collagen Sponge for Ectopic and Orthotopic Bone Formation and Comparison with Mammalian Cell Recombinant Human Bone Morphogenetic Protein-2
    Kim, In Sook
    Lee, Eui Nam
    Cho, Tae Hyung
    Song, Yun Mi
    Hwang, Soon Jung
    Oh, Ji Hye
    Park, Eun Kyung
    Koo, Tai Young
    Seo, Young-Kwon
    TISSUE ENGINEERING PART A, 2011, 17 (3-4) : 337 - 348